Does APREPITANT Cause Pustular psoriasis? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Pustular psoriasis have been filed in association with APREPITANT (CINVANTI). This represents 0.4% of all adverse event reports for APREPITANT.
22
Reports of Pustular psoriasis with APREPITANT
0.4%
of all APREPITANT reports
22
Deaths
22
Hospitalizations
How Dangerous Is Pustular psoriasis From APREPITANT?
Of the 22 reports, 22 (100.0%) resulted in death, 22 (100.0%) required hospitalization, and 22 (100.0%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
Which APREPITANT Alternatives Have Lower Pustular psoriasis Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL